expected weight loss with tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes How Tirzepatide Support Medical Weight

GLP-1 RAs are unique due to their A1C-lowering potential with effects on both fasting and postprandial blood glucose values

And she notes it is well-known that diabetic patients who aren't on these drugs may have blurring for an hour or two because fluctuations in blood sugar can affect vision temporarily

Exenatide, a synthetic version of exendin-4 produced industrially, was the first GLP-1RA approved for the market [exenatide twice daily (EX-BID)], followed by a long-acting formulation that improved the delivery system [exenatide once a week (EX-QW)]

Other side effects include vomiting (5% to 9%), diarrhea (8%), stomach pain (6% to 7%), and constipation (3% to 7%)